Home » Topics » BioWorld Science

BioWorld Science
RSS

SNAP-5399 presented at 211th ACS

April 19, 1996

XQ-870, fibrinogen antagonist presented by DuPont Merck

April 19, 1996

More antiplatelet agents from Thomae

April 19, 1996

Antiplatelet agents emerging from the Thomae pipeline

April 19, 1996

Corvas presents preclinical data for NAPc2

April 19, 1996

First clinical results for CVS-1123

April 19, 1996

SD-998, thrombin inhibitor

April 19, 1996

New series of thrombin inhibitors claimed by Thomae

April 19, 1996

Yamanouchi selects YM-471 for clinical development

April 19, 1996

Corvert now available in U.S.

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...